Curcumin Applications in Cancer Therapeutics

Summary

Curcumin, the principal polyphenol in turmeric, exhibits a broad spectrum of anticancer activities through its antioxidant, anti-inflammatory and pro-apoptotic properties. It modulates multiple oncogenic signalling pathways—such as NF-κB, STAT3 and PI3K/Akt—thereby inhibiting tumour growth, angiogenesis and metastasis. Despite promising preclinical and early clinical data, curcumin’s poor aqueous solubility and rapid metabolism have limited its systemic bioavailability. To overcome these challenges, diverse delivery platforms including nanoparticles, liposomes and polymeric conjugates have been developed, enhancing tumour targeting and therapeutic efficacy. Furthermore, curcumin demonstrates synergistic interactions with conventional chemotherapeutic agents, offering potential for dose reduction and diminished side effects. Collectively, these findings underscore curcumin’s global significance as a low-toxicity adjuvant in cancer treatment and motivate continued translational research.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Curcumin Applications in Cancer Therapeutics publication trend

The graph below shows the total number of articles in curcumin applications in cancer therapeutics across all publications each year (not limited to Nature Index journals).

Technical terms

Reactive oxygen species (ROS): Chemically reactive oxygen derivatives that can trigger cell signalling or oxidative damage.

KEAP1/NRF2/ARE pathway: A cytoprotective mechanism where NRF2 dissociates from KEAP1 and binds antioxidant response elements (ARE) to activate detoxifying genes.

MicroRNA-34 family (miR-34): Small non-coding RNAs that regulate gene expression post-transcriptionally, often functioning as tumour suppressors.

Nanoparticle delivery systems: Engineered carriers at the nanoscale designed to enhance the solubility, stability and targeted delivery of therapeutic molecules.

References

  1. Curcumin activates a ROS/KEAP1/NRF2/miR-34a/b/c cascade to suppress colorectal cancer metastasis. Cell Death & Differentiation (2023).
  2. A Review of Curcumin and Its Derivatives as Anticancer Agents. International Journal of Molecular Sciences (2019).
  3. Curcumin and Cancer. Nutrients (2019).
Nature Strategy Reports
Turn complex research questions into confident strategic decisions 

When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.

  • Benchmark your performance against global peers using robust, methodologically sound analysis.

  • Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.

  • Gain tailored, decision-ready recommendations aligned to your strategic priorities.

Talk to us to learn more about our data dashboards and bespoke strategy reports.

Nature Masterclasses
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.

Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:

  • Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.

  • Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.

  • Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.

Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.